Comparison of cilofungin and amphotericin B for therapy of murine candidiasis
- PMID: 2221875
- PMCID: PMC171887
- DOI: 10.1128/AAC.34.8.1619
Comparison of cilofungin and amphotericin B for therapy of murine candidiasis
Abstract
We compared the efficacies of cilofungin and amphotericin B treatment in a murine model of disseminated candidiasis. Three different dosages of each drug plus controls were evaluated. Statistically improved survival was noted only among mice treated with 1 mg of amphotericin B per kg of body weight (P less than 0.05). While all amphotericin B regimens and the two lower-dosage cilofungin regimens significantly reduced yeast cell counts in kidneys compared with the controls, the amphotericin B-treated mice had a significantly higher percentage of sterile kidneys following therapy compared with those treated with cilofungin (P = 0.0001).
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
